0000950142-01-500515.txt : 20011107
0000950142-01-500515.hdr.sgml : 20011107
ACCESSION NUMBER: 0000950142-01-500515
CONFORMED SUBMISSION TYPE: SC 13D/A
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20011102
GROUP MEMBERS: FRANK H. PEARL
GROUP MEMBERS: GEORGE SOROS
GROUP MEMBERS: PERSEUS CAPITAL, LLC
GROUP MEMBERS: PERSEUS MANAGEMENT, LLC
GROUP MEMBERS: PERSEUS, LLC
GROUP MEMBERS: PSV GP, LLC
GROUP MEMBERS: PSV PARTNERS, LLC
GROUP MEMBERS: PSV, LP
GROUP MEMBERS: RAPPAHANNOCK INVESTMENT CO
GROUP MEMBERS: SFM AH, INC.
GROUP MEMBERS: SFM PARTICIPATION, L.P.
GROUP MEMBERS: SOROS FUND MANAGEMENT, LLC
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: VIROPHARMA INC
CENTRAL INDEX KEY: 0000946840
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 232789550
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13D/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-48239
FILM NUMBER: 1774208
BUSINESS ADDRESS:
STREET 1: 405 EAGLEVIEW BLVD
STREET 2: PO BOX 5000
CITY: EXTON
STATE: PA
ZIP: 19341
BUSINESS PHONE: 6104587300
MAIL ADDRESS:
STREET 1: 76 GREAT VALLEY PARKWAY
CITY: MALVERN
STATE: PA
ZIP: 19355
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: SOROS GEORGE
CENTRAL INDEX KEY: 0000900203
STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000]
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13D/A
BUSINESS ADDRESS:
STREET 1: 888 SEVENTH AVENUE
STREET 2: 33RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10106
BUSINESS PHONE: 212-262--6
MAIL ADDRESS:
STREET 1: 888 SEVENTH AVE
STREET 2: 33RD FLR
CITY: NEW YORK
STATE: NY
ZIP: 10106
SC 13D/A
1
sc13da4-viropharma.txt
AMENDMENT NO. 4
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(AMENDMENT NO. 4)
VIROPHARMA INCORPORATED
(Name of Issuer)
COMMON STOCK, PAR VALUE $.002 PER SHARE
(Title of Class of Securities)
928241108
(CUSIP Number)
KENNETH M. SOCHA, ESQ.
PSV, LP
2099 PENNSYLVANIA AVENUE, N.W.
SUITE 900
WASHINGTON, D.C. 20006-1813
TEL. NO.: (202) 452-0101
(Name, Address and Telephone Number of
Person Authorized to Receive Notices
and Communications)
with a copy to
BRUCE A. GUTENPLAN, ESQ.
PAUL, WEISS, RIFKIND, WHARTON & GARRISON
1285 AVENUE OF THE AMERICAS
NEW YORK, NEW YORK 10019-6064
OCTOBER 29, 2001
(Date of Event which Requires Filing of
this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject to this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box [_].
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purposes of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes.)
CUSIP NO. 98241108 PAGE 2 OF 20
SCHEDULE 13D
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
PSV, LP
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [X]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
Not Applicable
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(D) OR 2(E)
[_]
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OR ORGANIZATION
Delaware
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF 1,518,146 (1)
SHARES --------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY 0
EACH --------------------------------------------
REPORTING 9 SOLE DISPOSITIVE POWER
PERSON 1,518,146 (1)
WITH --------------------------------------------
10 SHARED DISPOSITIVE POWER
0
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,518,146 (1)
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[X]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
7.9%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
PN
--------------------------------------------------------------------------------
* SEE INSTRUCTIONS BEFORE FILLING OUT
------------------------
1/ Includes Warrant to purchase an aggregate of 595,000 shares of Common
Stock.
CUSIP NO. 98241108 PAGE 3 OF 20
SCHEDULE 13D
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
PSV GP, LLC
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [X]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
Not Applicable
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(D) OR 2(E)
[_]
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OR ORGANIZATION
Delaware
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF 1,518,146 (1)
SHARES --------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY 0
EACH --------------------------------------------
REPORTING 9 SOLE DISPOSITIVE POWER
PERSON 1,518,146 (1)
WITH --------------------------------------------
10 SHARED DISPOSITIVE POWER
0
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,518,146 (1)
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[X]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
7.9%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
OO
--------------------------------------------------------------------------------
* SEE INSTRUCTIONS BEFORE FILLING OUT
------------------------
1/ Includes Warrant to purchase an aggregate of 595,000 shares of Common
Stock.
CUSIP NO. 98241108 PAGE 4 OF 20
SCHEDULE 13D
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
PSV Partners, LLC
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [X]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
Not Applicable
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(D) OR 2(E)
[_]
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OR ORGANIZATION
Delaware
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF 0
SHARES --------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY 595,000 (1)
EACH --------------------------------------------
REPORTING 9 SOLE DISPOSITIVE POWER
PERSON 0
WITH --------------------------------------------
10 SHARED DISPOSITIVE POWER
595,000 (1)
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
595,000 (1)
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[X]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
3.1%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
OO
--------------------------------------------------------------------------------
* SEE INSTRUCTIONS BEFORE FILLING OUT
------------------------
1/ Represents Warrant to purchase an aggregate of 595,000 shares of Common
Stock.
CUSIP NO. 98241108 PAGE 5 OF 20
SCHEDULE 13D
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
SFM Participation, L.P.
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [X]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
Not Applicable
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(D) OR 2(E)
[_]
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OR ORGANIZATION
Delaware
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF 923,146
SHARES --------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY 595,000 (1)
EACH --------------------------------------------
REPORTING 9 SOLE DISPOSITIVE POWER
PERSON 923,146
WITH --------------------------------------------
10 SHARED DISPOSITIVE POWER
595,000 (1)
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,518,146
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[X]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
7.9%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
PN
--------------------------------------------------------------------------------
* SEE INSTRUCTIONS BEFORE FILLING OUT
------------------------
1/ Represents Warrant to purchase an aggregate of 595,000 shares of Common
Stock.
CUSIP NO. 98241108 PAGE 6 OF 20
SCHEDULE 13D
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
SFM AH, Inc.
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [X]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
Not Applicable
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(D) OR 2(E)
[_]
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OR ORGANIZATION
Delaware
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF 923,146
SHARES --------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY 595,000 (1)
EACH --------------------------------------------
REPORTING 9 SOLE DISPOSITIVE POWER
PERSON 923,146
WITH --------------------------------------------
10 SHARED DISPOSITIVE POWER
595,000 (1)
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,518,146
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[X]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
7.9%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
CO
--------------------------------------------------------------------------------
* SEE INSTRUCTIONS BEFORE FILLING OUT
------------------------
1/ Represents Warrant to purchase an aggregate of 595,000 shares of Common
Stock.
CUSIP NO. 98241108 PAGE 7 OF 20
SCHEDULE 13D
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
Rappahannock Investment Company
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [X]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
Not Applicable
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(D) OR 2(E)
[_]
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OR ORGANIZATION
United States
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF 1,152,646
SHARES --------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY 834,397 (1)
EACH --------------------------------------------
REPORTING 9 SOLE DISPOSITIVE POWER
PERSON 1,152,646
WITH --------------------------------------------
10 SHARED DISPOSITIVE POWER
834,397 (1)
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,987,043
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[X]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
10.3%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
CO
--------------------------------------------------------------------------------
* SEE INSTRUCTIONS BEFORE FILLING OUT
------------------------
1/ Represents Warrant to purchase an aggregate of 595,000 shares of Common
Stock.
CUSIP NO. 98241108 PAGE 8 OF 20
SCHEDULE 13D
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
Frank H. Pearl (in the capacity described herein)
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [X]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
Not Applicable
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(D) OR 2(E)
[_]
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OR ORGANIZATION
United States
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF 1,152,646
SHARES --------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY 834,397 (1)
EACH --------------------------------------------
REPORTING 9 SOLE DISPOSITIVE POWER
PERSON 1,152,646
WITH --------------------------------------------
10 SHARED DISPOSITIVE POWER
834,397 (1)
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,987,043
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[X]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
10.3%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
--------------------------------------------------------------------------------
* SEE INSTRUCTIONS BEFORE FILLING OUT
------------------------
1/ Represents Warrant to purchase an aggregate of 595,000 shares of Common
Stock.
CUSIP NO. 98241108 PAGE 9 OF 20
SCHEDULE 13D
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
George Soros (in the capacity described herein)
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [X]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
Not Applicable
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(D) OR 2(E)
[_]
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OR ORGANIZATION
United States
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF 923,146
SHARES --------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY 595,000 (1)
EACH --------------------------------------------
REPORTING 9 SOLE DISPOSITIVE POWER
PERSON 923,146
WITH --------------------------------------------
10 SHARED DISPOSITIVE POWER
595,000 (1)
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,518,146
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[X]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
7.9%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IA
--------------------------------------------------------------------------------
* SEE INSTRUCTIONS BEFORE FILLING OUT
------------------------
1/ Represents Warrant to purchase an aggregate of 595,000 shares of Common
Stock.
CUSIP NO. 98241108 PAGE 10 OF 20
SCHEDULE 13D
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
Soros Fund Management LLC
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [X]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
Not Applicable
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(D) OR 2(E)
[_]
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OR ORGANIZATION
Delaware
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF 923,146
SHARES --------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY 595,000 (1)
EACH --------------------------------------------
REPORTING 9 SOLE DISPOSITIVE POWER
PERSON 923,146
WITH --------------------------------------------
10 SHARED DISPOSITIVE POWER
595,000 (1)
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,518,146
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[X]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
7.9%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
OO; IA
--------------------------------------------------------------------------------
* SEE INSTRUCTIONS BEFORE FILLING OUT
------------------------
1/ Represents Warrant to purchase an aggregate of 595,000 shares of Common
Stock.
CUSIP NO. 98241108 PAGE 11 OF 20
SCHEDULE 13D
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
Perseus Capital, LLC
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [X]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
Not Applicable
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(D) OR 2(E)
[_]
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OR ORGANIZATION
Delaware
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF 1,152,646
SHARES --------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY 0
EACH --------------------------------------------
REPORTING 9 SOLE DISPOSITIVE POWER
PERSON 1,152,646
WITH --------------------------------------------
10 SHARED DISPOSITIVE POWER
0
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,152,646
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[X]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
6.2%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
OO
--------------------------------------------------------------------------------
* SEE INSTRUCTIONS BEFORE FILLING OUT
CUSIP NO. 98241108 PAGE 12 OF 20
SCHEDULE 13D
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
Perseus Management, LLC
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [X]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
Not Applicable
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(D) OR 2(E)
[_]
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OR ORGANIZATION
Delaware
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF 1,152,646
SHARES --------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY 0
EACH --------------------------------------------
REPORTING 9 SOLE DISPOSITIVE POWER
PERSON 1,152,646
WITH --------------------------------------------
10 SHARED DISPOSITIVE POWER
0
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,152,646
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[X]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
6.2%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
OO
--------------------------------------------------------------------------------
* SEE INSTRUCTIONS BEFORE FILLING OUT
CUSIP NO. 98241108 PAGE 13 OF 20
SCHEDULE 13D
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
Perseus, LLC
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [X]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
Not Applicable
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(D) OR 2(E)
[_]
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OR ORGANIZATION
Delaware
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF 1,152,646
SHARES --------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY 239,397
EACH --------------------------------------------
REPORTING 9 SOLE DISPOSITIVE POWER
PERSON 1,152,646
WITH --------------------------------------------
10 SHARED DISPOSITIVE POWER
239,397
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,392,043
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[X]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
7.4%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
OO
--------------------------------------------------------------------------------
* SEE INSTRUCTIONS BEFORE FILLING OUT
CUSIP NO. 98241108 PAGE 14 OF 20
This Amendment No. 4 ("Amendment No. 4") to Schedule 13D is
filed by the undersigned to amend and supplement the Schedule 13D filed on May
17, 1999 (the "Original 13D"), as amended by Amendment No. 1 to the Schedule 13D
filed on July 1, 2000 (the "Amendment No. 1"), as amended by Amendment No. 2 to
the Schedule 13D filed on May 17, 2001 ("Amendment No. 2"), as amended by
Amendment No. 3 to the Schedule 13D filed on September 17, 2001 ("Amendment No.
3") relating to the common stock (the "Common Stock"), par value $.002 per
share, issued by ViroPharma Incorporated, a Delaware corporation (the
"Company"). Unless otherwise indicated, all capitalized terms shall have the
same meaning as provided in the Original 13D.
ITEM 1. SECURITY AND ISSUER.
No Change.
ITEM 2. IDENTITY AND BACKGROUND.
No change.
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.
No change.
ITEM 4. PURPOSE OF TRANSACTION.
Item 4 is hereby amended and supplemented as follows:
As discussed below in Item 5(c), each of the Purchaser and
Perseus Capital sold an aggregate of 250,000 and 20,500 shares of Common Stock,
respectively, pursuant to Rule 144 under the Securities Act of 1933, as amended
(the "Securities Act"). Without limiting the disclosure set forth elsewhere
herein, Perseus Capital currently intends to sell shares in an amount sufficient
to realize cash proceeds approximately equal to its aggregate original
investment in the Common Stock.
The disclosure under the caption "Additional Disclosure" in
Item 4 is hereby amended and restated in its entirety as follows:
ADDITIONAL DISCLOSURE
In accordance with Section 8.2 of the Investment Agreement,
the Purchaser made a written request that the Company file a registration
statement (the "Registration Statement") for an offering to be made on a
continuous basis pursuant to Rule 415 of the Securities Act registering the
resale from time to time of a portion of the Common Stock it beneficially owns
and the Common Stock issuable upon exercise of the Warrants. The Registration
Statement was declared effective by Securities and
CUSIP NO. 98241108 PAGE 15 OF 20
Exchange Commission on October 19, 2001. The Reporting Persons may from time to
time sell all or a portion the Common Stock, Warrant, or Common Stock issued
upon exercise of the Warrant in privately negotiated transactions or in the open
market pursuant to the Registration Statement or other exercise of their
registration rights or Rule 144, in each case, subject to prices for the Common
Stock deemed favorable by the Reporting Persons, the Company's business or
financial condition and other factors and conditions the Reporting Persons deem
appropriate and to the terms of the Investment Agreement and the Warrant, as the
case may be. Alternatively, the Reporting Persons may from time to time acquire
additional shares of Common Stock in privately negotiated transactions or in the
open market, in each case, subject to availability of Common Stock at prices
deemed favorable, the Company's business or financial condition and other
factors and conditions the Reporting Persons deem appropriate. In addition, the
Reporting Persons may formulate other purposes, plans or proposals regarding the
Company or any of its securities to the extent deemed advisable in light of
general investment and trading policies, market conditions or other factors.
Except as described in the Investment Agreement or the
Warrant, and as otherwise set forth in the Original 13D or any amendment
thereto, including this Amendment No. 4, no Reporting Person or any individual
otherwise identified in Item 2 has any present plans or proposals which relate
to or would result in any of the events described in Items (a) through (j) of
Item 4 of Schedule 13D.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.
Item 5 is hereby amended and restated in its entirety as
follows:
(a) As of the date hereof: (i) each of the Purchaser, PSV
GP, SFM Participation, SFM AH, Mr. Soros and SFM LLC may be deemed to
beneficially own an aggregate of 1,518,146 shares of Common Stock which, based
on calculations made in accordance with Rule 13d-3(d) and there being 18,699,695
shares of Common Stock outstanding as of August 31, 2001 as disclosed by the
Company in its Amendment No. 2 to the Registration Statement on Form S-3 as
filed with the Securities and Exchange Commission on October 10, 2001,
represents approximately 7.9% of the outstanding shares of Common Stock on a
diluted basis in accordance with Rule 13d-3(d); (ii) each of Rappahannock and
Mr. Pearl may be deemed to beneficially own an aggregate of 1,987,043 shares of
Common Stock (which includes the shares held by Perseus Capital and the Warrants
held by the Purchaser and an additional 239,397 shares of Common Stock
beneficially owned by New York Life BioVenture Partners LLC, a Delaware limited
CUSIP NO. 98241108 PAGE 16 OF 20
liability company ("New York Life"), as more fully discussed below) which, based
on calculations made in accordance with Rule 13d-3(d) and there being 18,699,695
shares of Common Stock outstanding as of August 31, 2001 as disclosed by the
Company in its Amendment No. 2 to the Registration Statement on Form S-3 as
filed with the Securities and Exchange Commission on October 10, 2001,
represents approximately 10.3% of the outstanding shares of Common Stock on a
diluted basis in accordance with Rule 13d-3(d); (iii) Perseus may be deemed to
beneficially own an aggregate of 1,392,043 shares of Common Stock (which
includes the shares held by Perseus Capital and an additional 239,397 shares of
Common Stock beneficially owned by New York Life, as more fully discussed below)
which, based on calculations made in accordance with Rule 13d-3(d) and there
being 18,699,695 shares of Common Stock outstanding as of August 31, 2001 as
disclosed by the Company in its Amendment No. 2 to the Registration Statement on
Form S-3 as filed with the Securities and Exchange Commission on October 10,
2001, represents approximately 7.4% of the outstanding shares of Common Stock on
a diluted basis in accordance with Rule 13d-3(d); (iv) each of Perseus Capital
and Perseus Management may be deemed to beneficially own an aggregate of
1,152,646 shares of Common Stock which, based on calculations made in accordance
with Rule 13d-3(d) and there being 18,699,695 shares of Common Stock outstanding
as of August 31, 2001 as disclosed by the Company in its Amendment No. 2 to the
Registration Statement on Form S-3 as filed with the Securities and Exchange
Commission on October 10, 2001, represents approximately 6.2% of the outstanding
shares of Common Stock on a diluted basis in accordance with Rule 13d-3(d); and
(v) PSV Partners may be deemed to beneficially own an aggregate of 595,000
shares of Common Stock which, based on calculations made in accordance with Rule
13d-3(d) and there being 18,699,695 shares of Common Stock outstanding as of
August 31, 2001 as disclosed by the Company in its Amendment No. 2 to the
Registration Statement on Form S-3 as filed with the Securities and Exchange
Commission on October 10, 2001, represents approximately 3.1% of the outstanding
shares of Common Stock on a diluted basis in accordance with Rule 13d-3(d). As
noted above, Perseus, Rappahannock and Mr. Pearl may be deemed to beneficially
own the 239,397 shares of Common Stock owned by New York Life. Mr. Pearl is the
sole shareholder of Rappahannock, which is the sole member of Perseus, a member
of Perseus Biotech Advisors, LLC ("Perseus Biotech Advisors"). Pursuant to a
management agreement executed on August 1, 2000 (the "Management Agreement"),
New York Life Investment Management, LLC, the sole manager of New York Life,
retained Perseus Biotech Advisors to act as investment manager
CUSIP NO. 98241108 PAGE 17 OF 20
of New York Life. The Management Agreement is a general agreement pursuant to
which Perseus Biotech Advisors became the investment manager of New York Life
with respect to its portfolio companies. Prior to August 1, 2000, New York Life
acquired 239,397 shares of Common Stock. As a result of the Management
Agreement, Perseus, Rappahannock and Mr. Pearl may be deemed to beneficially own
the 239,397 shares of Common Stock owned by New York Life.
(b) (i) Each of the Purchaser and PSV GP may be
deemed to have sole power to direct the voting and disposition of the 1,518,146
shares of Common Stock beneficially owned by the Purchaser. With respect to the
923,146 shares of Common Stock beneficially owned by the Purchaser, each of SFM
Participation, SFM AH, Mr. Soros and SFM LLC may be deemed to have sole power to
direct the voting and disposition of such shares. With respect to the 1,152,646
shares of Common Stock beneficially owned by Perseus Capital, each of Perseus
Management, Perseus, Rappahannock and Mr. Pearl may be deemed to have the sole
power to direct the voting and disposition of such shares.
(ii) By virtue of the relationships between and
among the Reporting Persons, each of PSV Partners, SFM Participation, SFM AH,
Rappahannock, Mr. Pearl, Mr. Soros and SFM LLC may be deemed to share the power
to direct the voting and disposition of the 595,000 shares of Common Stock
issuable upon exercise of the Warrant beneficially owned by the Purchaser.
(iii) Perseus, Rappahannock and Mr. Pearl may be
deemed to share the power to direct the voting and disposition of the 239,397
shares of Common Stock owned by New York Life. Each of the Reporting Persons,
other than Perseus, Rappahannock and Mr. Pearl, disclaim beneficial ownership of
the 239,397 shares of Common Stock owned by New York Life.
(c) Between October 10, 2001 and October 31, 2001, each
of the Purchaser and Perseus Capital sold the following number of shares under
Rule 144 on the dates and for the prices set forth below:
CUSIP NO. 98241108 PAGE 18 OF 20
PURCHASER
DATE SHARES SOLD PRICE
---- ----------- -----
10/10/01 28,000 $29.08
10/11/01 8,800 28.97
10/12/01 37,500 28.00
10/15/01 55,500 28.08
10/16/01 16,000 27.99
10/17/01 2,000 27.89
10/26/01 30,500 26.24
10/29/01 44,500 25.08
10/31/01 23,200 25.00
10/31/01 4,000 25.00
PERSEUS
DATE SHARES SOLD PRICE PER SHARE
---- ----------- ---------------
10/11/2001 12,000 $28.89
10/12/2001 600 28.00
10/15/2001 1,400 28.90
10/18/2001 500 27.50
10/19/2001 2,000 27.50
10/23/2001 4,000 27.53
All such sales were made in the open market.
(d) Each of the Reporting Persons affirms that, except as
set forth below, no person other than the Reporting Persons has the right to
receive or the power to direct the receipt of dividends from, or the proceeds
from the sale of, the shares of Common Stock owned by the Reporting Persons. The
partners of the Purchaser and the members of Perseus Capital have the right to
participate in the receipt of dividends from, or proceeds from the sale of, the
Securities held for the account of each of the Purchaser and Perseus Capital in
accordance with their ownership interests in each of the Purchaser and Perseus
Capital.
(e) No change.
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT
TO SECURITIES OF THE ISSUER.
No change.
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS.
Exhibit 1: Incorporate by reference the Power of
Attorney, filed as Exhibit 2 to Amendment
No. 1 to the Schedule 13D, appointing
Richard D. Holahan, Jr., Attorney-In-Fact
for George Soros.
CUSIP NO. 98241108 PAGE 19 OF 20
SIGNATURE
After reasonable inquiry and to the best of its knowledge and
belief, each of the undersigned certifies that the information set forth in this
statement is true, complete and correct.
Dated: November 2, 2001
PSV, LP
By: PSV GP, LLC,
General Partner
By: SFM Participation, L.P.,
Member
By: SFM AH, Inc.,
General Partner
By: /s/ Richard D. Holahan, Jr.
---------------------------------------
Name: Richard D. Holahan, Jr.
Title: Secretary
PSV GP, LLC
By: SFM Participation, L.P.,
Member
By: SFM AH, Inc.,
General Partner
By: /s/ Richard D. Holahan, Jr.
---------------------------------------
Name: Richard D. Holahan, Jr.
Title: Secretary
PSV PARTNERS, LLC
By: Rappahannock Investment Company,
Managing Member
By: /s/ Frank H. Pearl
---------------------------------------
Name: Frank H. Pearl
Title: Sole Shareholder
RAPPAHANNOCK INVESTMENT COMPANY
By: /s/ Frank H. Pearl
---------------------------------------
Name: Frank H. Pearl
Title: Sole Shareholder
MR. FRANK H. PEARL
By: /s/ Frank H. Pearl
---------------------------------------
Name: Frank H. Pearl
CUSIP NO. 98241108 PAGE 20 OF 20
SFM PARTICIPATION, L.P.
By: SFM AH, Inc.,
General Partner
By: /s/ Richard D. Holahan, Jr.
---------------------------------------
Name: Richard D. Holahan, Jr.
Title: Secretary
SFM AH, INC.
By: /s/ Richard D. Holahan, Jr.
---------------------------------------
Name: Richard D. Holahan, Jr.
Title: Secretary
MR. GEORGE SOROS
By: /s/ Richard D. Holahan, Jr.
---------------------------------------
Name: Richard D. Holahan, Jr.
Title: Attorney-in-fact
SOROS FUND MANAGEMENT LLC
By: /s/ Richard D. Holahan, Jr.
---------------------------------------
Name: Richard D. Holahan, Jr.
Title: Assistant General Counsel
PERSEUS CAPITAL, LLC
By: /s/ Kenneth M. Socha
---------------------------------------
Name: Kenneth M. Socha
Title: Executive Vice President
PERSEUS MANAGEMENT, LLC
By: /s/ Kenneth M. Socha
---------------------------------------
Name: Kenneth M. Socha
Title: Executive Vice President
PERSEUS, LLC
By: /s/ Kenneth M. Socha
---------------------------------------
Name: Kenneth M. Socha
Title: Executive Vice President